SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-036174
Filing Date
2020-06-12
Accepted
2020-06-12 06:59:22
Documents
1
Period of Report
2020-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6182
  Complete submission text file 0001209191-20-036174.txt   7491
Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-978-1200
FIBROGEN INC (Issuer) CIK: 0000921299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address LILLY CORPORATE CENTER INDIANAPOLIS IN 46285
Business Address
Conterno Enrique A (Reporting) CIK: 0001476151 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36740 | Film No.: 20958843